Clinicopathological Investigation of Vascular Endothelial Growth Factor and von Hippel–Lindau Gene-Related Protein Expression in Immunohistochemically Negative Pituitary Adenoma – Possible Involvement in Tumor Aggressiveness

Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3%

(2014) Y. Ogawa et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Coexistence of Sporadic Cerebellar Hemangioblastoma and Pituitary Null Cell Adenoma: Simultaneous Expression of von Hippel-Lindau Gene Product

(2012) Yoshiteru SHIMODA et al.   NEUROLOGIA MEDICO-CHIRURGICA

Clival Invasion on Multi-Detector CT in 390 Pituitary Macroadenomas: Correlation with Sex, Subtype and Rates of Operative Complication and Recurrence

(2011) X. Chen et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Somatostatin-Producing Atypical Null Cell Adenoma Manifesting as Severe Hypopituitarism and Rapid Deterioration—Case Report

(2010) Yoshikazu Ogawa et al.   ENDOCRINE PATHOLOGY

Atypical pituitary adenomas: incidence, clinical characteristics, and implications

(2010) Gabriel Zada et al.   JOURNAL OF NEUROSURGERY

Vascular Endothelial Growth Factor: Much More than an Angiogenesis Factor

(2010) Donald R. Senger   MOLECULAR BIOLOGY OF THE CELL

Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to the octreotide treatment

(2008) Masamichi Kurosaki et al.   NEUROLOGICAL RESEARCH

Hypoxia-inducible factor-1  expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma

(2007) C-Y Chai et al.   JOURNAL OF CLINICAL PATHOLOGY